Synovis Life Technologies Has Been Acquired by Baxter International

Baxter International (NYSE: BAX), a Deerfield, IL based diversified healthcare company, acquired Minneapolis, MN based Synovis Life Technologies (NASDAQ: SYNO), a developer of medical devices used primarily in surgical procedures for soft tissue repair, for a total enterprise value of approximately $260 million. The acquisition expands Baxter's regenerative medicine and BioSurgery franchise by adding biological and mechanical products from Synovis used for soft tissue repair and microsurgery in a variety of surgical procedures.

Tamarack Partners provides M&A advisory services to owners of lower middle market companies. For more information on this transaction or to speak with one of our transactional advisors about your business, Contact Us.